Atopic dermatitis/eczema
Overview
•Pruritus - cardinal symptom; intense, nocturnal, worse with heat/sweating
•Xerosis - dry, rough skin reflecting barrier failure
•Lichenification - thickened leathery skin from chronic scratching
•Vesicles - in acute flares or pompholyx subtype
•Onset - typically early childhood; 90% present before age 5
Investigations
•Clinical diagnosis - based on UK Working Party criteria (itch + 3 of: onset <2 yrs, flexural involvement, dry skin, personal/family atopic history, visible flexural eczema)
•Skin swab - bacterial culture if secondary infection suspected (Staph. aureus most common)
•Viral swab (HSV PCR) - urgent if eczema herpeticum suspected
•Patch testing - specialist setting; to identify allergic contact sensitisation
Management
•All patients: emollients as soap substitute; avoid aqueous cream (contains sodium lauryl sulphate); identify and avoid triggers
🥇 First-line
•emollients (e.g. Diprobase, Epaderm) - liberal and frequent application; cornerstone of all treatment
•First-line flare (face/flexures): hydrocortisone 1% - mild topical corticosteroid; thin skin absorbs more
•First-line flare (trunk/limbs): clobetasone butyrate 0.05% (Eumovate) - moderate potency; avoid on face
🥈 Second-line
•betamethasone valerate 0.1% (Betnovate) - potent; trunk/limbs only, never face; specialist guidance in children
•Second-line (face/flexures, steroid-sparing): tacrolimus 0.03% (children 2-15 yrs) or 0.1% (adults); pimecrolimus 1% - no skin-thinning effect
🥉 Third-line
•oral ciclosporin - severe refractory eczema in adults; monitor renal function and BP
•Third-line (biological): dupilumab (anti-IL-4/IL-13) - moderate-to-severe, failed systemic immunosuppression; NICE-approved; SC every 2 weeks
Complications
•Eczema herpeticum - HSV superinfection; medical emergency; IV aciclovir
•Topical corticosteroid side effects - skin atrophy, striae, telangiectasia, adrenal suppression (children with widespread potent steroid use)
•Sleep disturbance - from nocturnal pruritus; significant quality of life impact
•Psychological comorbidity - anxiety and depression more prevalent in moderate-to-severe eczema
Pompholyx (dyshidrotic eczema)
•Intensely itchy, deep-seated vesicles on palms, lateral fingers, and soles
•Triggered by heat, sweating, and humidity - worse in hot/humid environments
•Vesicles 1-2 mm, clear, tapioca-like; followed by scaling and fissuring
•More common in young adults; females > males
Eczema herpeticum
•HSV-1 superinfection of eczematous skin - medical emergency
•Widespread monomorphic punched-out erosions/vesicles, typically face and neck
•Systemic features: fever, lymphadenopathy, reduced oral intake, irritability
•Management: urgent hospital admission + IV aciclovir - do NOT give antibiotics alone or delay
Infected eczema
•Most commonly Staphylococcus aureus - weeping, crusting, pustules
•Oral: flucloxacillin; if penicillin-allergic and pregnant: erythromycin; if penicillin-allergic (non-pregnant): cefalexin
•Localised infection: topical fusidic acid may be sufficient
•Refer urgently if suspected eczema herpeticum - do not give antibiotics alone
Pregnancy-related dermatoses
Pregnancy dermatoses - key distinguishing features
| Feature | Atopic eruption of pregnancy | Pemphigoid gestationis | Polymorphic eruption of pregnancy (PEP) |
|---|---|---|---|
| Incidence | 1 in 300 - most common dermatosis in pregnancy | 1 in 1700 to 1 in 50,000 - rare | Common |
| Trimester | 2nd or 3rd trimester | 2nd or 3rd trimester | 3rd trimester / post-partum |
| Morphology | Itchy erythematous papules; excoriated nodules | Urticarial plaques progressing to tense vesicles/bullae | Urticarial papules and plaques |
| Distribution | Face, neck, chest, extensor limbs | Periumbilical - pathognomonic starting point | Within striae on abdomen; spares periumbilicus |
| Safety | Benign; no adverse fetal effects | Serious autoimmune disorder - autoantibodies to BP180 | Benign |